tiprankstipranks
Elevate Uranium Ltd (AU:EL8)
ASX:EL8
Want to see AU:EL8 full AI Analyst Report?

Elevate Uranium Ltd (EL8) AI Stock Analysis

26 Followers

Top Page

AU:EL8

Elevate Uranium Ltd

(Sydney:EL8)

Select Model
Select Model
Select Model
Neutral 48 (OpenAI - 5.2)
Rating:48Neutral
Price Target:
AU$0.33
▼(-2.35% Downside)
Action:ReiteratedDate:04/22/26
The score is mainly constrained by weak financial performance: ongoing losses and negative operating/free cash flow outweigh the benefit of rising revenue and a low-leverage balance sheet. Technicals are somewhat supportive with the price above major moving averages, but momentum signals are mixed. Valuation remains challenged due to negative earnings and no dividend support.
Positive Factors
Low leverage
A conservative leverage profile with a low debt-to-equity ratio reduces fixed financing costs and preserves balance sheet flexibility. For an exploration/development company this durable conservatism lengthens runway for drilling and project advancement without immediate debt pressure.
Negative Factors
Unprofitable operations
Persistent negative net income and EBIT indicate the business is not generating operating profits. Over a multi-month horizon this reduces internal funding capacity for resource definition and development, increases reliance on external capital, and raises execution risk if losses persist.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage
A conservative leverage profile with a low debt-to-equity ratio reduces fixed financing costs and preserves balance sheet flexibility. For an exploration/development company this durable conservatism lengthens runway for drilling and project advancement without immediate debt pressure.
Read all positive factors

Elevate Uranium Ltd (EL8) vs. iShares MSCI Australia ETF (EWA)

Elevate Uranium Ltd Business Overview & Revenue Model

Company Description
Elevate Uranium Ltd engages in the exploration and evaluation of uranium deposits. The company's principal projects include the Koppies, Hirabeb, Marenica, and Namib IV in Namibia. It also holds 100% interests in the Angela, Thatcher Soak, Oobagoo...
How the Company Makes Money
null...

Elevate Uranium Ltd Financial Statement Overview

Summary
Revenue growth is improving, but the company remains unprofitable with negative net income/EBIT and negative operating and free cash flow (ongoing cash burn). The balance sheet is a relative positive with low leverage and a stable capital structure, but weak profitability and cash generation dominate.
Income Statement
25
Negative
Balance Sheet
40
Negative
Cash Flow
30
Negative
BreakdownTTMJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue768.50K768.50K182.000.000.000.00
Gross Profit813.11K768.50K-121.67K-117.68K-85.52K-54.29K
EBITDA-11.03M-11.85M-10.62M-8.51M-5.68M-2.66M
Net Income-10.99M-12.32M-10.75M-8.63M-5.73M-2.60M
Balance Sheet
Total Assets45.64M25.46M13.26M12.54M19.33M9.96M
Cash, Cash Equivalents and Short-Term Investments36.65M21.71M10.83M10.06M15.81M6.66M
Total Debt390.56K432.41K74.21K146.03K177.27K99.29K
Total Liabilities1.52M1.57M1.48M1.02M838.59K429.54K
Stockholders Equity44.12M23.89M11.78M11.52M18.49M9.53M
Cash Flow
Free Cash Flow-13.74M-11.71M-9.31M-5.90M-4.49M-2.40M
Operating Cash Flow-13.27M-11.62M-9.24M-5.83M-4.38M-2.33M
Investing Cash Flow-3.50M-714.24K-73.79K-74.52K-137.62K-61.28K
Financing Cash Flow23.13M23.22M10.09M158.86K13.67M7.99M

Elevate Uranium Ltd Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.34
Price Trends
50DMA
0.32
Negative
100DMA
0.32
Negative
200DMA
0.32
Negative
Market Momentum
MACD
>-0.01
Negative
RSI
56.08
Neutral
STOCH
79.48
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:EL8, the sentiment is Positive. The current price of 0.34 is above the 20-day moving average (MA) of 0.28, above the 50-day MA of 0.32, and above the 200-day MA of 0.32, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 56.08 is Neutral, neither overbought nor oversold. The STOCH value of 79.48 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:EL8.

Elevate Uranium Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
65
Neutral
$15.17B7.614.09%5.20%3.87%-62.32%
56
Neutral
AU$147.82M-6.08-17.88%41.33%
48
Neutral
AU$153.77M-4.98-32.33%37.27%
46
Neutral
AU$241.52M-2.14-10.95%-32.89%
46
Neutral
AU$19.29M-30.09-1.07%-4.17%
45
Neutral
AU$182.98M-16.35-12.34%-1047.83%
40
Underperform
AU$6.46M-2.50-82.81%-161.54%
* Energy Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:EL8
Elevate Uranium Ltd
0.33
0.11
50.00%
AU:AEE
Aura Energy
0.15
0.03
26.09%
AU:BKY
Berkeley Energia
0.41
-0.17
-29.31%
AU:PEN
Peninsula Energy
0.54
0.08
17.65%
AU:ZEU
Zeus Resources Ltd.
0.01
0.00
0.00%
AU:EME
Energy Metals Ltd
0.09
<0.01
9.52%

Elevate Uranium Ltd Corporate Events

Elevate Uranium Lifts Koppies Resource to 76.2 Mlb with Namib IV Maiden Estimate
Apr 14, 2026
Elevate Uranium has reported a maiden inferred mineral resource estimate of 10.1 million pounds of U3O8 at its Namib IV deposit, part of the wholly owned Koppies Uranium Project in Namibia&#8217;s Erongo Region. The Namib IV resource, defined at a...
Elevate Uranium Moves General Meeting Materials Fully Online
Apr 9, 2026
Elevate Uranium Ltd has called a general meeting of shareholders for 8 May 2026 in West Perth, with proxy forms and communication preference notices to be sent separately by its share registry, Automic. In line with Australian corporate law, the c...
Elevate Uranium Moves to Digital-First Shareholder Meeting Process
Apr 9, 2026
Elevate Uranium Ltd has called a general meeting of shareholders to be held on 8 May 2026 in West Perth, setting 6 May 2026 as the record date to determine voting eligibility. The company is shifting to electronic distribution of meeting documents...
Elevate Uranium Releases Half-Year Financial Report for December 2025
Mar 12, 2026
Elevate Uranium Ltd has released its half-year financial report for the period ended 31 December 2025, providing consolidated financial statements and accompanying notes. The report includes profit or loss and other comprehensive income, financial...
Elevate Uranium Builds Critical Mass With 153Mlb Global Resource Base
Feb 8, 2026
Elevate Uranium has outlined a global resource base of 153 million pounds of U3O8 across two top&#8209;tier jurisdictions, positioning itself as an emerging mid&#8209;tier player in the uranium sector. The company reports four discoveries in four ...
Elevate Uranium Doubles Resource Grade at Namibia’s Marenica Project After Major Re-Estimate
Feb 4, 2026
Elevate Uranium has delivered a major upgrade to the Mineral Resource Estimate at its Marenica Uranium Project in Namibia, doubling the resource grade to 185 ppm U3O8 for 40.2 million pounds of contained uranium at a 100 ppm cut-off grade, and inc...
Elevate Uranium Options Lapse, Clarifying Capital Structure
Feb 3, 2026
Elevate Uranium Ltd has confirmed the expiry of 14,904,798 listed options (ASX code EL8AT), which were due to expire on 30 January 2026 with an exercise price of A$0.60 and lapsed without being exercised. The cessation of these options reduces the...
Elevate Uranium Options Lapse Simplifies Capital Structure
Feb 3, 2026
Elevate Uranium Ltd has confirmed that 14,904,798 unlisted Class EL8AT options, each exercisable at $0.60, expired on 30 January 2026. The lapse of these options marginally simplifies the company&#8217;s capital structure by removing a tranche of ...
Elevate Uranium Managing Director Increases Indirect Shareholding via Super Fund
Jan 22, 2026
Elevate Uranium Limited has disclosed changes in the securities held by Managing Director Murray Hill and his related entities, including his spouse and their self-managed superannuation fund. The notice details a net acquisition of 1,349,486 full...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 22, 2026